Moulédous L - Search Results

1

Pharmacological insight into the activation of the human neuropeptide FF2 receptor.

Talmont F, Veneziano R, Dietrich G, Moulédous L, Mollereau C, Zajac JM. Talmont F, et al. Among authors: mouledous l. Peptides. 2020 Dec;134:170406. doi: 10.1016/j.peptides.2020.170406. Epub 2020 Sep 10. Peptides. 2020. PMID: 32920044

2

Distinct mechanisms for activation of the opioid receptor-like 1 and kappa-opioid receptors by nociceptin and dynorphin A.

Mollereau C, Mouledous L, Lapalu S, Cambois G, Moisand C, Butour JL, Meunier JC. Mollereau C, et al. Among authors: mouledous l. Mol Pharmacol. 1999 Feb;55(2):324-31. doi: 10.1124/mol.55.2.324. Mol Pharmacol. 1999. PMID: 9927625

3

Characterization of a new radioiodinated probe for the alpha2C adrenoceptor in the mouse brain.

Dossin O, Moulédous L, Baudry X, Tafani JA, Mazarguil H, Zajac JM. Dossin O, et al. Among authors: mouledous l. Neurochem Int. 2000 Jan;36(1):7-18. doi: 10.1016/s0197-0186(99)00102-3. Neurochem Int. 2000. PMID: 10566954

4

Functional inactivation of the nociceptin receptor by alanine substitution of glutamine 286 at the C terminus of transmembrane segment VI: evidence from a site-directed mutagenesis study of the ORL1 receptor transmembrane-binding domain.

Mouledous L, Topham CM, Moisand C, Mollereau C, Meunier JC. Mouledous L, et al. Mol Pharmacol. 2000 Mar;57(3):495-502. doi: 10.1124/mol.57.3.495. Mol Pharmacol. 2000. PMID: 10692489

5

The nociceptin (ORL1) receptor: molecular cloning and functional architecture.

Meunier J, Mouledous L, Topham CM. Meunier J, et al. Among authors: mouledous l. Peptides. 2000 Jul;21(7):893-900. doi: 10.1016/s0196-9781(00)00225-4. Peptides. 2000. PMID: 10998522 Review.

6

Tissue distribution of the opioid receptor-like (ORL1) receptor.

Mollereau C, Mouledous L. Mollereau C, et al. Among authors: mouledous l. Peptides. 2000 Jul;21(7):907-17. doi: 10.1016/s0196-9781(00)00227-8. Peptides. 2000. PMID: 10998524 Review.

7

Neuropeptide FF-sensitive confinement of mu opioid receptor does not involve lipid rafts in SH-SY5Y cells.

Moulédous L, Merker S, Neasta J, Roux B, Zajac JM, Mollereau C. Moulédous L, et al. Biochem Biophys Res Commun. 2008 Aug 15;373(1):80-4. doi: 10.1016/j.bbrc.2008.05.174. Epub 2008 Jun 9. Biochem Biophys Res Commun. 2008. PMID: 18544342 Free article.

8

Central locomotor and cognitive effects of a NPFF receptor agonist in mouse.

Betourne A, Marty V, Ceccom J, Halley H, Lassalle JM, Zajac JM, Frances B, Mouledous L. Betourne A, et al. Among authors: mouledous l. Peptides. 2010 Feb;31(2):221-6. doi: 10.1016/j.peptides.2009.11.009. Epub 2009 Nov 18. Peptides. 2010. PMID: 19931330

9

Pharmacological characterization of the mouse NPFF2 receptor.

Talmont F, Moulédous L, Piedra-Garcia L, Schmitt M, Bihel F, Bourguignon JJ, Zajac JM, Mollereau C. Talmont F, et al. Among authors: mouledous l. Peptides. 2010 Feb;31(2):215-20. doi: 10.1016/j.peptides.2009.11.020. Epub 2009 Nov 26. Peptides. 2010. PMID: 19944730

10

Modulation by neuropeptide FF of the interaction of mu-opioid (MOP) receptor with G-proteins.

Kersanté F, Moulédous L, Zajac JM, Mollereau C. Kersanté F, et al. Among authors: mouledous l. Neurochem Int. 2010 May-Jun;56(6-7):768-73. doi: 10.1016/j.neuint.2010.02.014. Epub 2010 Mar 6. Neurochem Int. 2010. PMID: 20211672

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters